Younes, A <br/><br/>
CD30 ligand in lymphoma patients with CD30+ tumors.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 1997 
 - 3355-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1997.15.11.3355  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>CD30 Ligand<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Flow Cytometry<br/>Hodgkin Disease--blood<br/>Humans<br/>Ki-1 Antigen--blood<br/>Ligands<br/>Lymphocytes--immunology<br/>Lymphoma, Large-Cell, Anaplastic--blood<br/>Male<br/>Membrane Glycoproteins--blood<br/>Middle Aged<br/>Neoplasm Staging<br/>Polymerase Chain Reaction<br/>Prognosis